![]() | Up a level |
Rajabzadeh, A. and Ahmadvand, D. and Salmani, M.K. and Rahbarizadeh, F. and Hamidieh, A.A. (2021) A VHH-based anti-MUC1 chimeric antigen receptor for specific retargeting of human primary T cells to MUC1-positive cancer cells. Cell Journal, 22 (4). pp. 502-513.
Jafari Iri Sofla, F. and Rahbarizadeh, F. and Ahmadvand, D. and Nomani, A. and Vernet, E. (2019) Anti�HER2 single domain antibody-conjugated dendrimers for targeted delivery of truncated-Bid transgene to breast cancer cells. Journal of Bioactive and Compatible Polymers, 34 (1). pp. 39-57.
Rahbarizadeh, F. and Ahmadvand, D. and Moghimi, S.M. (2019) CAR T-cell bioengineering: Single variable domain of heavy chain antibody targeted CARs. Advanced Drug Delivery Reviews.
Ranjbar, S. and Rahbarizadeh, F. and Ahmadvand, D. (2019) Designing an ELP-intein system: toward a more realistic outlook. Preparative Biochemistry and Biotechnology, 49 (3). pp. 222-229.
Farasat, A. and Rahbarizadeh, F. and Ahmadvand, D. and Ranjbar, S. and Khoshtinat Nikkhoi, S. (2019) Effective suppression of tumour cells by oligoclonal HER2-targeted delivery of liposomal doxorubicin. Journal of Liposome Research, 29 (1). pp. 53-65.
Shariatifar, H. and Hakhamaneshi, M.-S. and Abolhasani, M. and Ahmadi, F.H. and Roshani, D. and Nikkhoo, B. and Abdi, M. and Ahmadvand, D. (2019) Immunofluorescent labeling of CD20 tumor marker with quantum dots for rapid and quantitative detection of diffuse large B-cell non-Hodgkin's lymphoma. Journal of Cellular Biochemistry, 120 (3). pp. 4564-4572.
Hashemi, M. and Mohammadi, J. and Omidi, M. and Smyth, H.D.C. and Muralidharan, B. and Milner, T.E. and Yadegari, A. and Ahmadvand, D. and Shalbaf, M. and Tayebi, L. (2019) Self-assembling of graphene oxide on carbon quantum dot loaded liposomes. Materials Science and Engineering C, 103.
Banihashemi, S.R. and Zavaran Hosseini, A. and Rahbarizadeh, F. and Ahmadvand, D. (2018) Development of specific nanobodies (VHH) for CD19 immunotargeting of human B-Lymphocytes. Iranian Journal of Basic Medical Sciences, 21 (5). pp. 455-464.
Banihashemi, S.R. and Zavaran Hosseini, A. and Rahbarizadeh, F. and Ahmadvand, D. (2018) Development of specific nanobodies (VHH) for CD19 immunotargeting of human B-Lymphocytes. Iranian Journal of Basic Medical Sciences, 21 (5). pp. 455-464.
Farasat, A. and Rahbarizadeh, F. and Ahmadvand, D. and Ranjbar, S. and Khoshtinat Nikkhoi, S. (2018) Effective suppression of tumour cells by oligoclonal HER2-targeted delivery of liposomal doxorubicin. Journal of Liposome Research. pp. 1-13.
Farasat, A. and Rahbarizadeh, F. and Ahmadvand, D. and Ranjbar, S. and Khoshtinat Nikkhoi, S. (2018) Effective suppression of tumour cells by oligoclonal HER2-targeted delivery of liposomal doxorubicin. Journal of Liposome Research. pp. 1-13.
Khoshtinat Nikkhoi, S. and Rahbarizadeh, F. and Ahmadvand, D. and Moghimi, S.M. (2018) Multivalent targeting and killing of HER2 overexpressing breast carcinoma cells with methotrexate-encapsulated tetra-specific non-overlapping variable domain heavy chain anti-HER2 antibody-PEG-liposomes: In vitro proof-of-concept. European Journal of Pharmaceutical Sciences, 122. pp. 42-50.
Khaleghi, S. and Rahbarizadeh, F. and Ahmadvand, D. and Malek, M. and Madaah Hosseini, H.R. (2016) The effect of superparamagnetic iron oxide nanoparticles surface engineering on relaxivity of magnetoliposome. Contrast Media and Molecular Imaging, 11 (5). pp. 340-349.
Wibroe, P.P. and Ahmadvand, D. and Oghabian, M.A. and Yaghmur, A. and Moghimi, S.M. (2016) An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome. Journal of Controlled Release, 221. pp. 1-8.
Montazerabadi, A.R. and Oghabian, M.A. and Irajirad, R. and Muhammadnejad, S. and Ahmadvand, D. and Hamid Delavari, H. and Mahdavi, S.R. (2015) Development of Gold-Coated Magnetic Nanoparticles as a Potential MRI Contrast Agent. Nano, 10 (4).
Jafari Iri Sofla, F. and Rahbarizadeh, F. and Ahmadvand, D. and Nomani, A. and Rahimi Jamnani, F. (2015) Specific gene delivery mediated by poly(ethylene glycol)-grafted polyamidoamine dendrimer modified with a novel HER2-targeting nanobody. Journal of Bioactive and Compatible Polymers, 30 (2). pp. 129-144.